Marble_7.png

PRIMER ON BIOELECTRONIC
REIMBURSEMENT MODELS

A CASE STUDY IN HEART FAILURE

cardiac.png

Overview

Neural data is the next frontier of precision medicine, powering a range of new bioelectronic, molecular, and digital therapies. New technologies in bioelectronics hold the promise of dramatically improving patients’ quality of life while reducing healthcare costs. However, current reimbursement strategies fail to account for the significant benefits that they deliver.

 

This primer has been produced by BIOS in collaboration with Legal & General and aims to inform new audiences on a range of topics relevant to bioelectronic reimbursement models. We hope it encourages discussion between healthcare stakeholders (including innovators and payors), which will in turn support increased innovation in the industry.

 

BIOS is planning further research to validate potential reimbursement models to deliver the best outcomes possible to both patients and wider healthcare systems. If you are interested in working with us on this mission, reach out to partnerships@bios.health.

Download the PDF here.

Point of Contact

Catherine Hanley
Programme Manager - Autonomic Therapies Initiative
BIOS Health

partnerships@bios.health

Marble_8.png
Marble_8.png

YOU MIGHT ALSO LIKE

Screenshot 2020-11-23 at 13.02.08 Copy 8.jpg

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Screenshot 2020-11-23 at 13.02.08 Copy 14.jpg

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Screenshot 2020-11-23 at 13.02.08 Copy 13.jpg

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Screenshot 2020-11-23 at 13.02.08 Copy 15.jpg

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.